Bristol-Myers (BMY) to Acquire ZymoGenetics (ZGEN) for $885 Million

By StockFrontRunners on Sep 08, 2010 with Comments 576

Bristol-Myers Squibb Co. (NYSE: BMY) announced on Tuesday it will purchase ZymoGenetics Inc. (Nasdaq: ZGEN) for $885 million in another move to gain complete ownership of a hepatitis C drug both companies are developing together

Read more:
Bristol-Myers (BMY) to Acquire ZymoGenetics (ZGEN) for $885 Million

Filed Under: Stock News Worldwide • Uncategorized

Tags: announced-on-tuesday • another-move • drug-both • nyse • squibb • tuesday • will-purchase • zgen

About the Author:

Comments (576)

Trackback URL

Comments are closed.

Archives
- February 2012 (13)
- January 2012 (37)
- December 2011 (25)
- November 2011 (39)
- October 2011 (30)
- September 2011 (24)
- August 2011 (40)
- July 2011 (29)
- June 2011 (4)
- May 2011 (4)
- April 2011 (273)
- March 2011 (432)
- February 2011 (374)
- January 2011 (472)
- December 2010 (384)
- November 2010 (163)
- October 2010 (397)
- September 2010 (323)
- August 2010 (412)
- July 2010 (432)
- June 2010 (343)
- May 2010 (205)
- April 2010 (216)
- March 2010 (184)
- February 2010 (100)
- January 2010 (139)
- December 2008 (2)
- November 2008 (3)
- October 2008 (1)
- April 2008 (1)
- March 2008 (2)
- December 2007 (1)
- October 2007 (1)
- August 2007 (1)
- July 2007 (1)
- April 2007 (1)
- February 2007 (1)
- July 2006 (1)
- May 2006 (1)

Bristol-Myers (BMY) to Acquire ZymoGenetics (ZGEN) for $885 Million

Comments (576)

Archives